Skip to main content

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1021223 LOS ANGELES, CA

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,107
+$1,446 QoQ
Shares Held
7
+250.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#735
of 784 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $15,557,323 across 9 Biotechnology names. ALNY ranks #6 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ALNY
Alnylam Pharmaceuticals, Inc.
This page
7 $2,107

All Filings in ALNY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,107 7
2026-03-31 $661 2
2025-12-31 $1,192 3
2025-09-30 $912 2
2025-06-30 $1,630 5
2024-12-31 $941 4
2024-03-31 $597 4
2023-12-31 $765 4
2023-09-30 $708 4
2023-06-30 $759 4
2022-03-31 $1,469 9
2020-12-31 $779 6